These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1591032)

  • 21. Safety of intracerebroventricular copper histidine in adult rats.
    Lem KE; Brinster LR; Tjurmina O; Lizak M; Lal S; Centeno JA; Liu PC; Godwin SC; Kaler SG
    Mol Genet Metab; 2007 May; 91(1):30-6. PubMed ID: 17336116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Síntesis y uso de histidinato de cobre en niños con enfermedad de Menkes en México.
    Flores-Pulido AA; Jiménez-Pérez VM; García-Chong NR
    Gac Med Mex; 2019; 155(2):191-195. PubMed ID: 31056589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and biochemical consequences of copper-histidine therapy in Menkes disease.
    Kreuder J; Otten A; Fuder H; Tümer Z; Tønnesen T; Horn N; Dralle D
    Eur J Pediatr; 1993 Oct; 152(10):828-32. PubMed ID: 8223785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Menkes' disease: long-term treatment with copper and D-penicillamine.
    Nadal D; Baerlocher K
    Eur J Pediatr; 1988 Aug; 147(6):621-5. PubMed ID: 3181204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Copper infusion therapy in Menkes syndrome.
    Tuchinda C; Suntornlohanakul S; Ratanarapee S; Ayudhya QD; Angsusingha K; Punnakanta L
    J Med Assoc Thai; 1984 Aug; 67(8):456-60. PubMed ID: 6520571
    [No Abstract]   [Full Text] [Related]  

  • 26. Menkes' disease: report of a case and determination of eumelanin and pheomelanin in hypopigmented hair.
    Tomita Y; Kondo Y; Ito S; Hara M; Yoshimura T; Igarashi H; Tagami H
    Dermatology; 1992; 185(1):66-8. PubMed ID: 1638075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correction of cerebrospinal fluid copper in Menkes kinky hair disease.
    Kollros PR; Dick RD; Brewer GJ
    Pediatr Neurol; 1991; 7(4):305-7. PubMed ID: 1930426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early treatment of Menkes disease with parenteral copper-histidine: long-term follow-up of four treated patients.
    Christodoulou J; Danks DM; Sarkar B; Baerlocher KE; Casey R; Horn N; Tümer Z; Clarke JT
    Am J Med Genet; 1998 Mar; 76(2):154-64. PubMed ID: 9511979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EPR spectroscopy of a clinically active (1:2) copper(II)-histidine complex used in the treatment of Menkes disease: a Fourier transform analysis of a fluid CW-EPR spectrum.
    Gala L; Lawson M; Jomova K; Zelenicky L; Congradyova A; Mazur M; Valko M
    Molecules; 2014 Jan; 19(1):980-91. PubMed ID: 24434671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insight into the gas-phase structure of a copper(II) L-histidine complex, the agent used to treat Menkes disease.
    Ziegler BE; Marta RA; Burt MB; McMahon TB
    Inorg Chem; 2014 Mar; 53(5):2349-51. PubMed ID: 24528202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case of Menkes' disease with nephrocalcinosis and chronic renal failure.
    Balestracci A; Caletti MG; Missoni M
    Pediatr Nephrol; 2009 Jun; 24(6):1255-6. PubMed ID: 19139924
    [No Abstract]   [Full Text] [Related]  

  • 32. Multiple polypoid masses in the gastrointestinal tract in patient with Menkes disease on copper-histidinate therapy.
    Sasaki G; Ishii T; Sato S; Hoshino K; Morikawa Y; Kodama H; Matsuo N; Takahashi T; Hasegawa T
    Eur J Pediatr; 2004 Dec; 163(12):745-6. PubMed ID: 15480778
    [No Abstract]   [Full Text] [Related]  

  • 33. XAS applied to pharmaceuticals: drug administration and bioavailability.
    Nicolis I; Deschamps P; Curis E; Corriol O; Acar V; Zerrouk N; Chaumeil JC; Guyon F; Bénazeth S
    J Synchrotron Radiat; 2001 Mar; 8(Pt 2):984-6. PubMed ID: 11513002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Menkes' Kinky hair syndrome: studies of copper metabolism and long term copper therapy.
    Williams DM; Atkin CL; Frens DB; Bray PF
    Pediatr Res; 1977 Jul; 11(7):823-6. PubMed ID: 876703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early copper therapy in classic Menkes disease patients with a novel splicing mutation.
    Kaler SG; Buist NR; Holmes CS; Goldstein DS; Miller RC; Gahl WA
    Ann Neurol; 1995 Dec; 38(6):921-8. PubMed ID: 8526465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Menkes kinky hair disease (Menkes syndrome). A case report.
    Fister P; Rakus J; Primec ZR; Strazisar BG
    Acta Dermatovenerol Alp Pannonica Adriat; 2006 Sep; 15(3):126-30. PubMed ID: 17053847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. X-ray structure of physiological copper(II)-bis(L-histidinato) complex.
    Deschamps P; Kulkarni PP; Sarkar B
    Inorg Chem; 2004 May; 43(11):3338-40. PubMed ID: 15154794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ineffective attempt at treatment of Menkes disease with copper and the value of the amniotic-cell labeled-copper incorporation test].
    Toso V; Moschini M; Maccarrone G; Cagnin G; Antonini D
    Riv Neurobiol; 1983; 29(1):92-9. PubMed ID: 6665456
    [No Abstract]   [Full Text] [Related]  

  • 39. [Menkes disease: experience in copper salts therapy].
    Guitet M; Campistol J; Medina M
    Rev Neurol; 1999 Jul 16-31; 29(2):127-30. PubMed ID: 10528324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Has Menckes' disease disappeared? Clinical picture and postnatal diagnosis].
    Tønnesen T; Gerdes AM; Horn N
    Ugeskr Laeger; 1989 Nov; 151(45):2975-7. PubMed ID: 2588391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.